RecruitingPhase not listedNCT06433765
A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
Sponsor: TG Therapeutics, Inc.
Wilmington, NC
1 recruiting multiple sclerosis studies with a site in Wilmington, NC.
All trials in Wilmington, NC · All Multiple Sclerosis trials
Sponsor: TG Therapeutics, Inc.
Wilmington, NC
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.